Onira Therapeutics is modifying cell dormancy to fight the persistence of cancer.
Oniria Therapeutics has raised $2.3M in total funding. The most recent round was Grant. The last funding was announced in May 2025.
Oniria Therapeutics's investors include European Union, BStartup - Banc Sabadell, Ministry of Science and Innovation of Spain, Fundacion Botin, Investigo.
Oniria Therapeutics is headquartered in Barcelona, Spain.
Onira Therapeutics is modifying cell dormancy to fight the persistence of cancer.
Oniria Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oniria Therapeutics — Funding & Investors." VCBacked, May 5, 2025, https://www.vcbacked.co/company/oniria-therapeutics. Accessed July 20, 2026.
VCBacked. (2025). Oniria Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/oniria-therapeutics
{{cite web |title=Oniria Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/oniria-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated